Fundamentals data is not available for this company.
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 46.94 | (517.42) | (541.76)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-26 | 171.76 | (432.02) | (446.93)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-27 | 400.62 | (344.57) | (348.12)¢ | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
MaxCyte signs cell platform deal with CRISPR and... | 14-Mar-2017 | ShareCast |
Currency | US Dollars |
Share Price | $ 56.60 |
Change Today | $ 1.19 |
% Change | 2.15 % |
52 Week High | $68.14 |
52 Week Low | $32.38 |
Volume | 2,181,047 |
Shares Issued | 47.19m |
Market Cap | $2,671.12m |
RiskGrade | 311 |
Strong Buy | 6 |
Buy | 10 |
Neutral | 10 |
Sell | 2 |
Strong Sell | 0 |
Total | 28 |
Time | Volume / Share Price |
16:00 | 180,860 @ $56.60 |
15:59 | 100 @ $56.64 |
15:59 | 100 @ $56.63 |
15:59 | 221 @ $56.61 |
15:59 | 200 @ $56.61 |
You are here: research